Wipro partners with Transcell Oncologics to transform vaccine safety assessment

By applying augmented intelligence to the vaccine development process, the solution can predict adverse neurovirulent impacts resulting from vaccinations, said Wipro in a press release. Currently, vaccine safety assessment often includes testing on animals to measure adverse impacts. Using Wipro HOLMES instead, researchers and biopharmaceutical companies have a new and fully viable solution and alternative.

Leave a Comment!

Your email address will not be published. Required fields are marked *